Resources

 

Fact Sheets

Fact Sheet: Morning Consult Prescription Drug Pricing Poll

AMERICANS FACE FINANCIAL CHALLENGES AS A RESULT OF INCREASING DRUG PRICES More than one in four American voters reported (26%) that they or a family member had 26% financial difficulty affording a prescribed medication in the last 12 months. VOTERS OVERWHELMINGLY WANT CONGRESS TO ACT LACK OF ACTION WILL IMPACT VOTE IN NEXT ELECTION

09-14-2021

Fact Sheet: Innovation

 For far too long Big Pharma has used the excuse that research and development (R&D) costs justify out-of-control prescription drug prices and that solutions to lower prices threaten innovation into new breakthroughs. These tired arguments, which Big Pharma wields like a shield to protect the industry’s anti-competitive and price-hiking practices, simply don’t hold up

06-7-2021

Fact Sheet: Cancer Drug Prices

THE PROBLEM: A CRISIS OF AFFORDABILITY The out-of-control prices set by Big Pharma on prescription drugs used to treat cancer have created a crisis of affordability — and placed breakthrough treatments out-of-reach for too many American patients. Patients and families should never have to face heart-wrenching choices between paying for their cancer treatment or

04-15-2021

Drug Pricing Overview – 117th Congress

02-1-2021

Fact Sheet: OUT-OF-CONTROL DRUG PRICES AN URGENT CONCERN FOR AMERICAN FAMILIES

Ninety-six percent of voters agree lowering drug prices is an important challenge facing Americans. Seventy-one percent say lowering drug prices is “very important.”

01-22-2021

Fact Sheet: Patent Abuse

Prescription drug prices are out-of-control thanks to the anti-competitive tactics and price-gouging practices of Big Pharma. Despite an escalating crisis of affordability, made worse by the economic impact of the COVID-19 pandemic, brand name drug companies continue to engage in anti-competitive behavior and price-gouging tactics in order to keep prices high and pad their

09-25-2020

Fact Sheet: Oversight Hearings

AN OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE The U.S. House of Representatives Committee on Oversight and Reform is scheduled to hold two days of hearings with Big Pharma executives on September 30 and October 1. Executives for brand name drug giants including Bristol Myers Squibb/Celgene, Amgen and Novartis are slated to testify. Lawmakers must

09-24-2020

Fact Sheet: No Price Hikes

Prescription drug prices are out-of-control. Too many Americans were already unable to afford their medications and resorting to dangerous measures like rationing — before the historic economic uncertainty of the current crisis. It is critical patients are able to take their medications as prescribed in order to stay healthy. Now is not the time

06-1-2020

Fact Sheet: KEEP YOUR PROMISE: CONGRESS MUST ACT TO HOLD BIG PHARMA ACCOUNTABLE, LOWER DRUG PRICES

THE CRISIS OF RISING PRESCRIPTION DRUG PRICES: The anti-competitive tactics and price-gouging practices of Big Pharma have created a crisis of prescription drug affordability in America. Today, as many as one-in-four Americans are unable to afford their medications. Despite the mounting crisis, brand name drug makers continue increasing prices and fighting to evade responsibility.

01-14-2020

Document: CSRxP Letter to Senate Finance Committee

The Campaign for Sustainable Rx Pricing (CSRxP) wishes to commend you for your strong bipartisan efforts to lower prescription drug prices for Americans by moving forward with the U.S. Senate Committee on Finance package on drug pricing. CSRxP believes that the Senate Finance package is a good first step in slowing the unsustainable growth

07-24-2019

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.